The United States market has been flat over the last week, but it has seen a significant rise of 34% over the past 12 months, with earnings forecasted to grow by 15% annually. In this context, identifying high growth tech stocks involves looking for companies that not only demonstrate strong revenue potential and innovation but also align well with these promising market conditions.

Top 10 High Growth Tech Companies In The United States

Click here to see the full list of 252 stocks from our US High Growth Tech and AI Stocks screener.

Let's uncover some gems from our specialized screener.

Iovance Biotherapeutics

Simply Wall St Growth Rating: ★★★★★☆

Overview: Iovance Biotherapeutics, Inc. is a commercial-stage biotechnology company focused on developing and commercializing cell therapies for metastatic melanoma and other solid tumor cancers in the United States, with a market cap of $2.84 billion.

Operations: Iovance Biotherapeutics generates revenue primarily from its therapies using autologous tumor infiltrating lymphocytes (TIL), amounting to $32.77 million. The company is focused on the treatment of metastatic melanoma and other solid tumor cancers in the U.S.

Iovance Biotherapeutics has demonstrated significant strides in revenue growth, with a reported increase from $0.238 million to $31.11 million year-over-year for Q2 2024. This surge of 45.3% per annum is anticipated to outpace the US market's average, setting a robust trajectory compared to the broader industry's growth rate of 8.7%. Moreover, earnings are expected to climb by 66.28% annually, reflecting an optimistic outlook despite current unprofitability and shareholder dilution over the past year. The company's recent presentations at high-profile healthcare conferences underscore its active engagement with the investor community and commitment to transparency during pivotal growth phases.

• Dive into the specifics of Iovance Biotherapeutics here with our thorough health report.

• Gain insights into Iovance Biotherapeutics' historical performance by reviewing our past performance report.

Fair Isaac

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Fair Isaac Corporation specializes in developing analytic, software, and digital decisioning technologies that help businesses automate and enhance decision-making processes globally, with a market cap of $46.97 billion.

Operations: The company generates revenue primarily through its Scores segment, contributing $866 million, and its Software segment, which brings in $787.45 million.

Fair Isaac's strategic focus on fraud prevention and operational optimization is evident in its recent collaborations and product enhancements. Partnering with Jersey Telecom, FICO developed the Scam Signal, reducing scam impacts by 41% through real-time data analysis—a testament to its innovative approach in tackling financial crimes. Additionally, FICO's engagement with Mexico's CENACE to enhance utility operations underscores its capability in applying AI across sectors, saving the government $300 million annually. These initiatives reflect a robust application of technology that not only addresses immediate client needs but also sets a precedent for future industry standards. With R&D expenses up 12.4%, reflecting an ongoing commitment to innovation, and earnings growth projected at 18.3% annually, Fair Isaac is positioning itself as a crucial player in tech-driven operational solutions.

• Click here and access our complete health analysis report to understand the dynamics of Fair Isaac.

• Explore historical data to track Fair Isaac's performance over time in our Past section.

TKO Group Holdings

Simply Wall St Growth Rating: ★★★★☆☆

Overview: TKO Group Holdings, Inc. is a sports and entertainment company with a market capitalization of approximately $20.86 billion.

Operations: TKO Group Holdings generates revenue primarily through its UFC segment, which contributes approximately $1.39 billion. Segment adjustments account for an additional $1.16 billion in the financials.

TKO Group Holdings stands out with its robust revenue growth forecast at 9.9% annually, surpassing the U.S. market average of 8.7%. This growth is supported by significant R&D investments, which are not only high but strategically aligned with future profitability; for instance, earnings are expected to surge by an impressive 74.5% per year. Recently, TKO raised its full-year revenue guidance to between $2.67 billion and $2.745 billion after strong mid-year performances and completed a substantial share repurchase in April, emphasizing confidence in its financial health and strategic direction.

• Click here to discover the nuances of TKO Group Holdings with our detailed analytical health report.

• Gain insights into TKO Group Holdings' past trends and performance with our Past report.

Key Takeaways

• Get an in-depth perspective on all 252 US High Growth Tech and AI Stocks by using our screener here.

• Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.

• Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Contemplating Other Strategies?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NasdaqGM:IOVA NYSE:FICO and NYSE:TKO.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com